AMYLIN IMMUNOREACTIVITY IN THE RAT TRACHEA AND CHARACTERIZATION OF THE INTERACTION OF AMYLIN AND SOMATOSTATIN ON AIRWAY MUCUS SECRETION

被引:5
作者
WAGNER, U
BREDENBROKER, D
BARTH, PJ
FEHMANN, HC
VONWICHERT, P
机构
[1] UNIV MARBURG,DEPT INTERNAL MED,CLIN RES UNIT GASTROINTESTINAL ENDOCRINOL,D-35033 MARBURG,GERMANY
[2] UNIV MARBURG,DEPT PATHOL,D-35033 MARBURG,GERMANY
关键词
AMYLIN; MUCUS SECRETION; RAT; SOMATOSTATIN; TRACHEA;
D O I
10.1007/BF02576799
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Amylin is a peptide containing 37 amino acids that is mainly expressed in pancreatic B-cells and cosecreted with insulin. It is the major component of the islet amyloid typically found in non-insulin-dependent diabetes mellitus. The amylin mRNA is present in RNA isolated from lung, and amylin receptors have been detected in lung membranes. Recently, amylin was shown to be a potent stimulator of airway mucus secretion. In this study, we characterized the site of amylin expression in rat trachea using a highly specific antiserum and the functional interaction of amylin with somatostatin-14 in mucus secreting cells. Amylin-like immunoreactivity is present in epithelial cells of submucous gland acini. The expres sion pattern varies, since some acini showed strong staining while others were negative. In addition, some columnar cells of the tracheal lining epithelium are strongly stained. Amylin applied submucosally is a potent stimulator of airway mucus secretion. Somatostatin inhibits this effect. Amylin may influence airway mucus secretion by paracrine and endocrine mechanisms, and our data suggest that amylin and somatostatin belong to the increasing number of peptides that are known to influence airway function.
引用
收藏
页码:289 / 296
页数:8
相关论文
共 28 条
[1]   INVESTIGATION AND CHARACTERIZATION OF BINDING-SITES FOR ISLET AMYLOID POLYPEPTIDE IN RAT MEMBRANES [J].
BHOGAL, R ;
SMITH, DM ;
BLOOM, SR .
ENDOCRINOLOGY, 1992, 130 (02) :906-913
[2]  
BRAIN SD, 1990, AM J PATHOL, V136, P487
[3]   PURIFICATION AND CHARACTERIZATION OF A PEPTIDE FROM AMYLOID-RICH PANCREASES OF TYPE-2 DIABETIC-PATIENTS [J].
COOPER, GJS ;
WILLIS, AC ;
CLARK, A ;
TURNER, RC ;
SIM, RB ;
REID, KBM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (23) :8628-8632
[4]  
DATTA HK, 1989, BIOCHEM BIOPH RES CO, V162, P2876
[5]   COSECRETION OF AMYLIN AND INSULIN FROM ISOLATED RAT PANCREAS [J].
FEHMANN, HC ;
WEBER, V ;
GOKE, R ;
GOKE, B ;
ARNOLD, R .
FEBS LETTERS, 1990, 262 (02) :279-281
[6]   EXPRESSION OF THE RAT AMYLIN (IAPP DAP) GENE [J].
FERRIER, GJM ;
PIERSON, AM ;
JONES, PM ;
BLOOM, SR ;
GIRGIS, SI ;
LEGON, S .
JOURNAL OF MOLECULAR ENDOCRINOLOGY, 1989, 3 (01) :R1-R4
[7]   ISLET AMYLOID POLYPEPTIDE INHIBITS INSULIN-SECRETION IN CONSCIOUS RATS [J].
FURNSINN, C ;
LEUVENINK, H ;
RODEN, M ;
NOWOTNY, P ;
SCHNEIDER, B ;
ROHAC, M ;
PIEBER, T ;
CLODI, M ;
WALDHAUSL, W .
AMERICAN JOURNAL OF PHYSIOLOGY, 1994, 267 (02) :E300-E305
[8]   ANTIINSULIN EFFECTS OF AMYLIN AND CALCITONIN-GENE-RELATED PEPTIDE ON HEPATIC GLYCOGEN-METABOLISM [J].
GOMEZFOIX, AM ;
RODRIGUEZGIL, JE ;
GUINOVART, JJ .
BIOCHEMICAL JOURNAL, 1991, 276 :607-610
[9]   BASAL AND STIMULATED PLASMA-LEVELS OF PANCREATIC AMYLIN INDICATE ITS CO-SECRETION WITH INSULIN IN HUMANS [J].
HARTTER, E ;
SVOBODA, T ;
LUDVIK, B ;
SCHULLER, M ;
LELL, B ;
KUENBURG, E ;
BRUNNBAUER, M ;
WOLOSZCZUK, W ;
PRAGER, R .
DIABETOLOGIA, 1991, 34 (01) :52-54
[10]  
JOHNSON KH, 1989, NEW ENGL J MED, V321, P513